BIOPIA is a non-profit collaborative effort of European labs with expertise in biotherapeutical immunogenicity and a spin-off from ABIRISK. The aim is to raise awareness about immunogenicity by:
Providing tests for anti-drug antibodies (ADA) and drug levels and thereby help clinicians assess treatment responses in their patients
Connect European labs and hospitals, with the goal of a having a more efficient implementation of drug levels and ADA in clinical routine